Lessons learned in breast cancer surgery

British Journal of Surgery

Volumn 101, Issue 3, 2014, Pages 145-147

  Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BREAST TUMOR; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; METHODOLOGY; MOLECULARLY TARGETED THERAPY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATIENT CARE; REVIEW; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MOLECULAR TARGETED THERAPY; PATIENT CARE TEAM; SENTINEL LYMPH NODE BIOPSY;

EID: 84893682919     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9407     Document Type: Review

References (20)

1. Halsted WS,. I. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Arch Surg 1894; 20: 497-501.
2. Keynes G., Conservative treatment of cancer of the breast. Br Med J 1937; 2: 643-666.3.
3. Atkins H, Hayward JL, Klugman DJ, Wayte AB,. Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J 1972; 2: 423-429.
4. Fentiman IS,. Long-term follow-up of the first breast conservation trial: Guy's Wide Excision Study. Breast 2000; 9: 5-8.
5. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al., Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-1232.
6. Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V,. Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg 1998; 41: 471-481.
7. Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM,. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 2010; 17: 1375-1391.
8. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, et al., Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29: 341-350.
9. Leidenius M, Leivonen M,., Vironen J, von Smitten K,. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005; 92: 23-31.
10. van Wely BJ, van den Wildenberg FJ, Gobardhan P, van Dalen T, Borel Rinkes IH, Theunissen EB, et al., Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2012; 38: 925-931.
11. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al., Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 30: 569-575.
12. Clinical Effectiveness Unit, Royal College of Surgeons of England. National Mastectomy and Breast Reconstruction Audit 2009. A National Audit of Provision and Outcomes of Mastectomy and Breast Reconstruction Surgery for Women in England. Second Annual Report 2009. http://www.rcseng.ac.uk/surgeons/ research/surgical-research/docs/national-mastectomy-and-breast-reconstruction- audit-second-report-2009 [accessed 29 November 2013].
13. Hind D, Wyld L, Beverley CB, Reed MW,. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev 2006; (1)CD004272.
14. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al., Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263-2271.
15. Department of Health. The NHS Cancer Plan. Department of Health: London, 2000.
16. Stefoski Mikeljevic J, Haward RA, Johnston C, Sainsbury R, Forman D,. Surgeon workload and survival from breast cancer. Br J Cancer 2003; 89: 487-491.
17. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS,. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 2012; 344: e2718.
18. Sørlie T, Perou CM, Tibshirani R, Aas T, Geislar S, Johnsen H, et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10 869-10 874.
19. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al., The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007; 13: 2329-2334.
20. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al., The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352.